HHS sends proposed drug pricing rule to White House for review
Comments
The White House announced on Thursday that a proposed drug pricing rule drafted by the Department of Health & Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) is currently pending its review.
An economically significant proposed
Recommended For You
More Trending News
Related Stocks
SymbolLast Price% ChgPFE–Pfizer Inc.JNJ–Johnson & JohnsonMRK–Merck & Co., Inc.GSK–GSK plc
Trending Analysis
Trending News